--Lannett and HEC to Co-develop Insulin Aspart; Lannett Granted Exclusive US Commercialization Rights--
PR Newswire
PHILADELPHIA, Feb. 9, 2021
PR Newswire
PHILADELPHIA, Feb. 9, 2021
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey